283 related articles for article (PubMed ID: 29519579)
1. A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.
Yamamoto S; Matsuo K; Nagakubo D; Higashiyama S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
J Pharmacol Sci; 2018 Mar; 136(3):165-171. PubMed ID: 29519579
[TBL] [Abstract][Full Text] [Related]
2. CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma.
Matsuo K; Itoh T; Koyama A; Imamura R; Kawai S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
Cancer Lett; 2016 Aug; 378(1):16-22. PubMed ID: 27132989
[TBL] [Abstract][Full Text] [Related]
3. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.
Bayry J; Tchilian EZ; Davies MN; Forbes EK; Draper SJ; Kaveri SV; Hill AV; Kazatchkine MD; Beverley PC; Flower DR; Tough DF
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10221-6. PubMed ID: 18621704
[TBL] [Abstract][Full Text] [Related]
4. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant-active aqueous extracts from Artemisia rupestris L. improve immune responses through TLR4 signaling pathway.
Zhang A; Yang Y; Wang Y; Zhao G; Yang X; Wang D; Wang B
Vaccine; 2017 Feb; 35(7):1037-1045. PubMed ID: 28111143
[TBL] [Abstract][Full Text] [Related]
7. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
Front Immunol; 2018; 9():2775. PubMed ID: 30542351
[TBL] [Abstract][Full Text] [Related]
8. Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells.
Hao S; Han X; Wang D; Yang Y; Li Q; Li X; Qiu CH
Immunology; 2016 Jun; 148(2):174-86. PubMed ID: 26868141
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
[TBL] [Abstract][Full Text] [Related]
10. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.
Dubois A; Deruytter N; Adams B; Kanda A; Delbauve S; Fleury S; Torres D; François A; Pétein M; Goldman M; Dombrowicz D; Flamand V
J Immunol; 2010 Jul; 185(2):884-91. PubMed ID: 20562264
[TBL] [Abstract][Full Text] [Related]
12. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.
Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F
ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
[TBL] [Abstract][Full Text] [Related]
14. A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.
Pere H; Montier Y; Bayry J; Quintin-Colonna F; Merillon N; Dransart E; Badoual C; Gey A; Ravel P; Marcheteau E; Batteux F; Sandoval F; Adotevi O; Chiu C; Garcia S; Tanchot C; Lone YC; Ferreira LC; Nelson BH; Hanahan D; Fridman WH; Johannes L; Tartour E
Blood; 2011 Nov; 118(18):4853-62. PubMed ID: 21908423
[TBL] [Abstract][Full Text] [Related]
15. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
Kamath AT; Valenti MP; Rochat AF; Agger EM; Lingnau K; von Gabain A; Andersen P; Lambert PH; Siegrist CA
Eur J Immunol; 2008 May; 38(5):1247-56. PubMed ID: 18412160
[TBL] [Abstract][Full Text] [Related]
16. Enhanced allergen-induced airway inflammation in paucity of lymph node T cell (plt) mutant mice.
Grinnan D; Sung SS; Dougherty JA; Knowles AR; Allen MB; Rose CE; Nakano H; Gunn MD; Fu SM; Rose CE
J Allergy Clin Immunol; 2006 Dec; 118(6):1234-41. PubMed ID: 17157652
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
[TBL] [Abstract][Full Text] [Related]
18. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
19. Global Gene Expression of T Cells Is Differentially Regulated by Peritoneal Dendritic Cell Subsets in an IL-2 Dependent Manner.
Sohn M; Na HY; Shin HS; Ryu SH; Park S; In H; Choi W; Park JS; Hwang S; Chu MK; Park CG
Front Immunol; 2021; 12():648348. PubMed ID: 34079542
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma.
Ren S; Wang Q; Zhang Y; Song Y; Dong X; Zhang W; Qin X; Liu M; Yu T
Int Immunopharmacol; 2018 Nov; 64():69-77. PubMed ID: 30149266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
